Optalert today announced that vehicles fitted with its Johns Drowsiness Scale (JDS) algorithm are now rolling off production lines for a leading European OEM – marking the first time a clinically validated, false-alert-free driver monitoring system has entered mass automotive production. For drivers who have grown tired of being beeped at, buzzed and warned by systems that cry wolf, the wait is finally over.
The problem that has been annoying drivers for years
Anyone who has driven a new car in the past five years knows the feeling: a sudden chime, a flashing icon, perhaps a vibrating seat – all triggered because you glanced at the instrument cluster, adjusted your sunglasses, or simply blinked some dust out of your eye. Driver monitoring systems (DMS), rushed to market in response to well-intentioned safety regulations, have created a new and widespread source of in-cabin frustration: the false alert.
The root cause is a fundamental flaw in how most systems define impairment. Rather than measuring what is actually happening neurologically inside the driver’s brain, they infer it from crude, outward proxies – a yawn, a nod of the head, an eyelid flutter. These signals are ambiguous at best. A tired-looking squint into low afternoon sun, a yawn from boredom rather than fatigue, a momentary head-turn to check a mirror: All can trigger an alert. Simple systems cannot tell the difference.
The benchmark these systems are calibrated against makes things worse. Most rely on the Karolinska Sleepiness Scale (KSS) – a self-reported, subjective questionnaire – as their scientific ground truth. The KSS asks drivers to rate how tired they feel. It correlates poorly with actual measured impairment, particularly in the early stages of drowsiness when intervention matters most. Systems built on a subjective yardstick are, by design, imprecise.
The consequences have been well-documented. Consumer reviews, automotive media, and regulatory feedback have catalogued the same complaints: alerts at highway speeds when the driver is demonstrably attentive; systems that cannot distinguish a second coffee-fuelled commuter from a microsleep risk; warnings so frequent and so wrong that drivers simply switch the feature off. A safety system that drivers disable is worse than no system at all.
“It is no wonder there was consumer backlash,” says Optalert CEO Scott Coles. “The automotive industry deployed monitoring systems that respond to the wrong signals. The JDS measures impairment objectively – the neurological state that actually precedes an accident – with an accuracy no subjective measure can match.”
More accurate detection: How science fixes the annoyance
The link between false alerts and driver annoyance is not trivial. Human factors research has consistently shown that Aesop’s “Boy Who Cried Wolf” occurs in practice: Alarm fatigue – the desensitisation caused by repeated false alerts – degrades response to genuine warnings. In the automotive context, this means that every unnecessary DMS alert does double damage: It irritates the driver in the moment, and it trains them to ignore the system in the future.
Reducing false alerts is therefore not merely a comfort improvement. It is a safety imperative. A system that alerts only when impairment is genuinely present preserves the driver’s trust in, and compliance with, every alert it issues. It keeps the cabin calm, the driver focused, and the technology credible. Done right, an accurate DMS becomes invisible – present and watchful, but not nagging.
This is the transformation Optalert has brought to the car. Rather than inferring impairment from ambiguous surface behaviours, the JDS measures the neurological state of the driver directly by analysing eyelid movements with clinical-grade precision. As drowsiness deepens, characteristic changes in eyelid kinematics emerge that are not under voluntary control and cannot be suppressed or mimicked by unrelated behaviours. A driver adjusting their sunglasses does not produce these patterns. A driver on the edge of a microsleep does.
The result is a system that stays silent when the driver is fine, and alerts with authority when they are not. Cars fitted with Optalert technology become noticeably less annoying – because the only alerts that sound are the ones that matter.
The science behind the JDS
The Johns Drowsiness Scale (JDS) scores drowsiness on a validated 0.0–10.0 scale using blepharometry — the precise measurement of eyelid movements captured by the in-cabin camera. It detects impairment 15–30 minutes before a driver reaches a critical threshold, giving the advanced driver assistance system (ADAS) time to proactively intervene gradually and non-intrusively, rather than with a jarring emergency alert.
The algorithm has been validated across more than 140 peer-reviewed studies and has been assessed by Harvard Medical School as “commensurate with gold standard laboratory measures” of drowsiness. This depth of scientific validation is unmatched in the automotive DMS space.
The complementary Optalert Intoxication Scale (OIS) extends the same precision to alcohol-related impairment, enabling soft countermeasures from the ADAS — invisible adjustments that reduce risk without alerting the driver at all.
DMS 2.0: The bar has been raised above mere compliance
The deployment arrives as the EU General Safety Regulation (GSR) mandates driver monitoring across new vehicle categories, and as Euro NCAP increasingly scores systems on the quality of their impairment detection rather than mere compliance. OEMs under pressure to deliver systems that satisfy both regulators and consumers now have a proven path: The JDS and OIS provide the scientific rigour for regulatory confidence and the accuracy required to eliminate the false alerts that have caused so much customer dissatisfaction.
Optalert’s entry into mass production is a signal that the first generation of driver monitoring systems is being superseded – and that the standard for what a DMS should achieve has permanently shifted.
About Optalert
Optalert is a Melbourne-based medical technology company dedicated to the objective measurement of drowsiness and impairment. Its technology is deployed across mining, rail, long-haul transport, and automotive sectors globally.
The Johns Drowsiness Scale™ (JDS), developed by a team of researchers including Optalert founder Dr. Murray Johns, is the only validated biomarker of driver impairment based on eyelid movement analysis. It is the most rigorously peer-reviewed drowsiness measurement technology available.
The Optalert Intoxication Scale (OIS) is the most accurate measurement of impairment due to intoxication and allows for soft countermeasures from the advanced driver assistance system (ADAS). These are invisible to the driver yet significantly reduce risk.
Optalert’s consumer sleep screening application, Owl Eye, brings the same underlying science to individuals seeking to understand their sleep health.
For further information, contact Optalert at info@optalert.com or visit www.optalert.com.
